India’s Chemco Group to Establish PET Preforms Factory in Bahrain

The Chemco Group, a leading Indian manufacturer of PET jars, has announced plans to set up a plastics packaging unit in Bahrain. The new factory will be established at the Bahrain International Investment Park in Salman Industrial City and will primarily engage in the manufacture of polyethylene terephthalate (PET) preforms. These PET preforms can be converted into PET jars and bottles of various shapes and sizes.

With this decision, Chemco’s investment in Bahrain up to 2015 will likely touch $10 million, eventually expanding in a systematic manner to double by 2017. When the new facility becomes operational, it will likely create 80 locals jobs, and around 20 more jobs would be added as the factory expands by 2017. In this context, a year-on-year growth of 15-20 per cent is expected.

The decision was finalized in a meeting between Chemco Group officials and the Kamal Ahmed, EDB’s acting CEO. The company said that it will look to supply products manufactured at this facility to both regional as well as local companies. The Chemco Group will be able to gain a license for operations in Bahrain with the support of the EDB, is primarily engaged in attracting FDI into Bahrain.

Ram Saraogi, the MD and chairman of the Chemco Group, the company zeroed in on Bahrain as it offers a unique business environment and an economy that is diverse while also offering a locational advantage from the Gulf market standpoint. The Chemco Group boasts a 26% market share in the PET preforms market in Asia; it was established in 1980. Its PET bottles are used in a variety of industries such as food and beverages and other products for brands such as Pepsi, Coca Cola and Reckitt Benckiser.

Pain Management Devices Market is Expected to Reach USD 5.0 Billion Globally in 2018: Transparency Market Research

According to a new market report published by Transparency Market Research , "Pain Management Devices Market (Electrical Stimulators, Radiofrequency Ablation, Analgesic Pumps, Neurostimulation Devices) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018", in 2011, the global pain management devices market was valued at USD 2.0 billion and is expected to grow at a CAGR of 13.1% from 2012 to 2018 to reach a market of USD 5.0 billion by 2018.

Browse the full report at: http://www.transparencymarketresearch.com/pain-management-drugs-devices.html

Increased sophistication and technological advances have revolutionized the pain management sector. Significant research to understand various pain sensations and their neurotransmission processes has helped in pain reduction to a great extent. A rise in aging population has consequently led to a rise in chronic diseases such as arthritis, diabetes and cancer. In addition, serious side-effects caused due to prolonged use of pain management drugs have triggered the growth of the pain management devices market.

Pain management devices comprise a variety of instruments such as electrical stimulators, analgesic pumps, radiofrequency ablation and neurostimulation devices. Robust support from healthcare institutes, universities and hospitals coupled with positive involvement from government bodies has unquestionably assisted in further growth of this sector. Companies in this sector are collaboratively working towards the introduction of innovative products which would satisfy the unmet needs of patients. Moreover, limitations like miniaturization, achievement of read out time and cost efficiency are being worked on by all the major players of this market.

Electrical stimulators especially the TENS (Transcutaneous Electrical Nerve Stimulators) are currently the most widely used by patients. The market for electrical stimulators was valued to be USD 208.7 million in year 2011 and is expected to grow at a CAGR of 8.2% from year 2012 to 2018. Although electrical stimulators and analgesic pumps are currently the most commonly used devices, radiofrequency ablation (RF ablation) and neurostimulation devices are anticipated to register high growth rate in the coming years of forecast. The rise in neuropathic diseases such as trigeminal neuralgia, peripheral neuralgia and spinal injuries has encouraged the growth of the neurostimulation devices market, which is slated to grow at a CAGR of 15.2% from 2012 to 2018.

Geographically, the North American region constituted the largest market in the year 2011; however, Asia is predicted to foresee the highest growth rate of 21.7% from 2012 to 2018. This growth has been attributed to increase in disease awareness and rising disposable incomes. In addition, the Asian region has been predicted to have the highest incidence rates of cancer and diabetes by 2020, by the World Health Organization. Favorable reimbursement policies and research funding by governments in the region will also provide the required impetus for the growth of the market.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Browse the full report with TOC at: http://www.transparencymarketresearch.com/pain-management-drugs-devices.html